Published in Lancet on July 16, 1988
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet (2011) 2.50
The dynamics of human cytomegalovirus replication in vivo. J Exp Med (1999) 2.19
Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections. J Clin Microbiol (1992) 2.14
Restriction endonuclease analysis of human and bovine group B streptococci for epidemiologic study. J Clin Microbiol (1989) 1.87
New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev (2000) 1.75
B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies. PLoS Pathog (2011) 1.16
Quantitative measurement of cytomegalovirus-specific IgG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection. Clin Exp Immunol (1990) 1.16
Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection. J Clin Microbiol (1990) 1.14
Strain-specific neutralization of human cytomegalovirus isolates by human sera. J Virol (1999) 1.05
Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay. J Clin Microbiol (2008) 0.97
Detection of human cytomegalovirus antigenaemia: a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients. Thorax (1995) 0.93
Human cytomegalovirus infection. Thorax (1989) 0.88
Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection. Med Microbiol Immunol (2008) 0.82
Impaired direct priming of CD8 T cells by donor-derived cytomegalovirus following kidney transplantation. J Am Soc Nephrol (2013) 0.81
Strain-specific neutralizing antibody responses against human cytomegalovirus envelope glycoprotein N. Clin Vaccine Immunol (2012) 0.81
Current status of renal transplantation. West J Med (1990) 0.81
Natural killer cell dependent within-host competition arises during multiple MCMV infection: consequences for viral transmission and evolution. PLoS Pathog (2013) 0.80
Evaluation of a novel immunoglobulin A capture enzyme immunoassay for diagnosis of cytomegalovirus infection in renal and heart transplant recipients. Eur J Clin Microbiol Infect Dis (1997) 0.78
Risk factors for viral reactivation following bone marrow transplantation. Ann Hematol (1992) 0.78
Molecular biology of cytomegalovirus. Int J Exp Pathol (1990) 0.77
Factors influencing the occurrence of active cytomegalovirus (CMV) infections after organ transplantation. Clin Exp Immunol (1993) 0.77
Cytomegalovirus disease in African-American kidney transplant patients. Transpl Infect Dis (2012) 0.75
A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med (2003) 21.55
Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med (1998) 5.79
Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene. Am J Hum Genet (1992) 4.80
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet (2000) 4.67
Clinical studies on submicroscopic subtelomeric rearrangements: a checklist. J Med Genet (2001) 3.28
Open access clinic providing HIV-I antibody results on day of testing: the first twelve months. BMJ (1991) 3.17
Molecular basis of opsonic defect in immunodeficient children. Lancet (1991) 3.00
Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci. Lancet (1984) 2.65
Unilateral leptomeningeal enhancement after carotid stent insertion detected by magnetic resonance imaging. Stroke (2000) 2.33
Screening for cystic fibrosis carriers. Lancet (1992) 2.32
Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet (1989) 2.23
The association of Angelman's syndrome with deletions within 15q11-13. J Med Genet (1989) 2.19
The dynamics of human cytomegalovirus replication in vivo. J Exp Med (1999) 2.19
Factors associated with active systemic lupus erythematosus after endstage renal disease. J Rheumatol (1998) 2.15
Neuroimaging for non-accidental head injury in childhood: a proposed protocol. Clin Radiol (2003) 2.15
TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax (2000) 2.14
Comparison of Doppler ultrasound, magnetic resonance angiographic techniques and catheter angiography in evaluation of carotid stenosis. Clin Radiol (2000) 2.11
Frequency and natural history of subdural haemorrhages in babies and relation to obstetric factors. Lancet (2004) 2.09
Congenital cytomegalovirus infection: diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum. Pediatrics (1982) 2.07
Wegener's granulomatosis: observations on 18 patients with severe renal disease. Q J Med (1983) 2.07
Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease. Lancet (1994) 2.05
Long-term outcome of peritoneal dialysis in infants. J Pediatr (2000) 2.01
On-line acquisition of the output of AutoAnalyzers. J Clin Pathol (1969) 1.96
Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet (1987) 1.89
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis (1998) 1.88
Cardiac rhabdomyomata in tuberous sclerosis: their course and diagnostic value. Arch Dis Child (1989) 1.85
The natural history of human immunodeficiency virus infection in a haemophilic cohort. Br J Haematol (1989) 1.84
Comparison of ultrasound and magnetic resonance imaging in 100 singleton pregnancies with suspected brain abnormalities. BJOG (2004) 1.83
Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet (1997) 1.83
Human mannose-binding protein functions as an opsonin for influenza A viruses. J Clin Invest (1993) 1.80
Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. J Infect Dis (1997) 1.77
HHV-6 in AIDS. Lancet (1994) 1.76
Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet (1977) 1.71
Investigating the functional anatomy of empathy and forgiveness. Neuroreport (2001) 1.69
Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS (1997) 1.68
Noise levels in a clinical chemistry laboratory. J Clin Pathol (1970) 1.68
Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections. J Infect Dis (1983) 1.67
Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet (2001) 1.66
Use of monoclonal antibodies for the diagnosis of cytomegalovirus infection by the detection of early antigen fluorescent foci (DEAFF) in cell culture. J Med Virol (1987) 1.65
Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol (2002) 1.63
A clinical study of type 1 neurofibromatosis in north west England. J Med Genet (1999) 1.62
The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am J Med (2001) 1.62
A genetic register for von Hippel-Lindau disease. J Med Genet (1996) 1.61
First-trimester prenatal diagnosis of cystic fibrosis with linked DNA probes. Lancet (1986) 1.61
Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancet (1980) 1.60
Serum levels of ATP: creatine phosphotransferase (creatine kinase). The normal range and effect of muscular activity. Clin Chim Acta (1966) 1.59
Abdominal hernias in patients receiving continuous ambulatory peritoneal dialysis. Br Med J (Clin Res Ed) (1981) 1.59
Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease. Bone Marrow Transplant (1998) 1.58
Spinal-cord involvement in diabetic peripheral neuropathy. Lancet (2001) 1.57
Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection. AIDS (1992) 1.56
Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med (1991) 1.56
Involvement of the anterior lobe of the cerebellar vermis in perinatal profound hypoxia. AJNR Am J Neuroradiol (2007) 1.55
The effects of dehydration on brain volume -- preliminary results. Int J Sports Med (2005) 1.55
Confidential inquiry into families with two siblings with cystic fibrosis. Arch Dis Child (1997) 1.54
SARS transmission among hospital workers in Hong Kong. Emerg Infect Dis (2004) 1.53
HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor. Nature (1990) 1.52
Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis: a randomized prospective multicenter study. Am J Kidney Dis (1999) 1.49
Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody. J Clin Pathol (1982) 1.47
Serum enzymes in diseases of the thyroid gland. J Clin Pathol (1965) 1.46
Diabetic patients with IgA nephropathy and diabetic glomerulosclerosis. Mod Pathol (1993) 1.46
Post-renal transplant distal limb bone pain. An under-recognized complication of transplantation distinct from avascular necrosis of bone? Transplantation (1995) 1.45
Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther (2007) 1.45
Acute pancreatitis and diabetic ketoacidosis in accidental hypothermia and hypothermic myxoedema. Br Med J (1973) 1.45
Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain (2000) 1.45
Beta 2 microglobulin enhances the infectivity of cytomegalovirus and when bound to the virus enables class I HLA molecules to be used as a virus receptor. J Gen Virol (1987) 1.44
Serum-enzymes in relation to electrocardiographic changes in accidental hypothermia. Lancet (1968) 1.43
Viral burden in HIV infection. Nature (1994) 1.43
Progress towards interrupting intrauterine transmission of cytomegalovirus? Rev Med Virol (2005) 1.42
Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy. Nephrol Dial Transplant (1989) 1.39
Choice of cross size in stereology--a cautionary note. Neuroradiology (2003) 1.39
Adverse interaction between warfarin and indomethacin. Drug Saf (1994) 1.38
A prospective study of primary cytomegalovirus infection during pregnancy: final report. Br J Obstet Gynaecol (1984) 1.38
Cyclosporin-induced renal magnesium leak in renal transplant patients. Nephrol Dial Transplant (1990) 1.38
Quantification of human cytomegalovirus DNA using the polymerase chain reaction. J Gen Virol (1992) 1.38
Amplification refractory mutation system for prenatal diagnosis and carrier assessment in cystic fibrosis. Lancet (1990) 1.36
Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis (2004) 1.35
Sixteen months experience with cyclosporin-A in human kidney transplantation. Transplant Proc (1981) 1.35
An improved radioimmunoassay method for the detection of IgG antibodies against cytomegalovirus. J Virol Methods (1986) 1.35
Simplified quantification of urinary protein excretion in children. Clin Nephrol (1988) 1.35
Use of the polymerase chain reaction to analyse sequence variation within a major neutralizing epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus. J Gen Virol (1991) 1.34
Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis (1999) 1.34
Macrocephaly with cutis marmorata, haemangioma and syndactyly--a distinctive overgrowth syndrome. Clin Dysmorphol (1997) 1.33
Importance of dialysis adequacy in mortality and morbidity of chinese CAPD patients. Kidney Int (2000) 1.33
Cytomegalovirus strain AD169 binds beta 2 microglobulin in vitro after release from cells. J Gen Virol (1987) 1.32
A prospective study of primary cytomegalovirus infection in pregnant women. Br J Obstet Gynaecol (1980) 1.31
Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases. BMJ (1996) 1.31
Intracranial MR venography in children: normal anatomy and variations. AJNR Am J Neuroradiol (2004) 1.31
Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis (2000) 1.31
Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am J Obstet Gynecol (1988) 1.30
A comparison of complement fixation, indirect immunofluorescence for viral late antigens, and anti-complement immunofluorescence tests for the detection of cytomegalovirus specific serum antibodies. J Clin Pathol (1978) 1.30
Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy. Proc Natl Acad Sci U S A (2000) 1.30